ClinCalc Pro
Menu
PsychiatryAddiction

Opioid Use Disorder

Opioid substitution therapy (methadone / buprenorphine), naloxone provision, harm reduction, comorbidity.

Source: Orange Book (Drug misuse and dependence — UK guidelines on clinical management 2017); NICE NG241

Step 1 of ~4
info

Assessment

DSM-5 OUD: ≥2 criteria within 12 months: tolerance, withdrawal, larger use than intended, persistent desire to cut down, time spent obtaining, social/occupational impact, continued use despite harm, hazardous use, craving, role failure, interpersonal problems, withdrawal of activities. Severity by criteria count: mild 2–3, moderate 4–5, severe ≥6. Baseline: • Bloods: FBC, U&E, LFTs, BBV (HIV, HBV, HCV), syphilis. • Urine drug screen. • Pregnancy test in women. • ECG (QTc — methadone risk). • Mental health screening. • Social: housing, family, employment, criminal justice. • Domestic abuse + safeguarding (children at home).

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only. Always apply local guidelines and clinical judgement.